White Spot Disease in Shrimp: Hepatopancreatic Microsporidiasis from Enterocytozoon hepatopenaei (EHP) and Co-infections

Introduction

White spot disease in shrimp is a term historically associated with viral infections caused by white spot syndrome virus (WSSV). However, a distinct and economically significant condition known as hepatopancreatic microsporidiasis, caused by the obligate intracellular parasite Enterocytozoon hepatopenaei (EHP), has emerged as a major constraint to penaeid shrimp aquaculture globally. EHP is a microsporidian parasite that infects the hepatopancreas and anterior midgut epithelium of shrimp, leading to chronic growth retardation, reduced feed conversion efficiency, and increased susceptibility to secondary bacterial infections [1, 2]. This article provides an exhaustive review of EHP biology, transmission dynamics, histopathological features, molecular diagnostic methods, interactions with Vibrio species, and management strategies centered on PCR-based broodstock screening.

Etiology and Taxonomy

Enterocytozoon hepatopenaei belongs to the phylum Microsporidia, a group of spore-forming, obligate intracellular parasites that were once considered protozoa but are now classified as fungi or a sister group to fungi [3]. The genus Enterocytozoon includes the human pathogen E. bieneusi, but EHP is distinct and specific to crustacean hosts, primarily penaeid shrimp such as Penaeus vannamei (Pacific white shrimp) and Penaeus monodon (black tiger shrimp) [4]. EHP spores are small, ovoid, and measure approximately 1.0 to 1.5 micrometers in length, containing a polar filament that is essential for host cell invasion [5].

Transmission and Epidemiology

EHP transmission occurs via both horizontal and vertical routes. Horizontal transmission is the predominant pathway, mediated by the ingestion of spores shed into the water column or present in contaminated feed, feces, and sediment [6]. Cannibalism of infected moribund shrimp also facilitates spread within ponds [7]. Vertical transmission, though less documented, has been suggested by the detection of EHP DNA in ovarian tissue and nauplii from infected broodstock, indicating potential transovarial passage [8].

Environmental factors such as high stocking density, poor water quality, and elevated organic load exacerbate transmission rates [9]. EHP spores are highly resilient, surviving in pond sediments and biofilms for extended periods, which complicates eradication efforts [10]. The parasite has been reported across major shrimp-producing regions in Southeast Asia, India, China, and Latin America, with prevalence rates in some hatcheries exceeding 80% [11, 12].

Pathogenesis and Histopathology

EHP specifically targets the hepatopancreatic tubule epithelial cells and the anterior midgut epithelium. After spore germination, the polar filament everts and penetrates the host cell membrane, injecting the sporoplasm into the cytoplasm [13]. The parasite undergoes merogony and sporogony within the host cell cytoplasm, leading to the formation of mature spores that are released upon cell lysis [14].

Histopathological examination of infected hepatopancreas reveals characteristic lesions. At low magnification, the hepatopancreas appears pale and atrophied. Microscopic findings include:

• Necrosis and sloughing of tubular epithelial cells.
• Presence of basophilic or eosinophilic cytoplasmic inclusions representing developmental stages of the parasite.
• Intertubular hemocytic infiltration and fibrosis in chronic cases.
• Loss of tubular architecture and reduced numbers of R, B, F, and E cells [15, 16].

The functional consequence is a severe impairment of digestive enzyme secretion and nutrient absorption, leading to stunted growth, poor feed conversion, and a condition commonly referred to as "white feces syndrome" when co-infections with Vibrio spp. are present [17].

Clinical Signs and Gross Pathology

Infected shrimp do not typically exhibit acute mortality. Instead, the disease manifests as a chronic, progressive condition. Clinical signs include:

• Reduced growth rate and size heterogeneity within the population.
• Soft shells and lethargy.
• An empty or partially empty gastrointestinal tract.
• White or pale discoloration of the hepatopancreas visible through the carapace.
• In severe cases, the presence of white fecal strings, indicative of enteric involvement [18, 19].

These signs are often subtle and may be mistaken for nutritional deficiencies or other pathogens, underscoring the need for definitive laboratory diagnosis.

Molecular Diagnostics: Quantitative PCR (qPCR)

The gold standard for EHP detection is quantitative polymerase chain reaction (qPCR), which offers high sensitivity and specificity. Several qPCR assays target the small subunit ribosomal RNA (SSU rRNA) gene, the internal transcribed spacer (ITS) region, or the spore wall protein (SWP) gene [20, 21]. The SSU rRNA gene is the most commonly used target due to its multi-copy nature, which enhances assay sensitivity.

A typical qPCR protocol involves the following steps:

1. Sample Collection: Hepatopancreas tissue, feces, or water samples are collected aseptically.
2. DNA Extraction: Commercial DNA extraction kits using silica membrane columns or magnetic beads are employed. Mechanical lysis with bead beating is recommended to disrupt the tough spore wall [22].
3. Primer and Probe Design: Primers targeting the EHP SSU rRNA gene (e.g., EHP-510F and EHP-510R) produce an amplicon of approximately 510 base pairs. A hydrolysis probe labeled with a fluorophore (e.g., FAM) and a quencher (e.g., BHQ1) is used for real-time detection [23].
4. Amplification Conditions: Thermal cycling typically includes an initial denaturation at 95 degrees Celsius for 10 minutes, followed by 40 cycles of 95 degrees Celsius for 15 seconds and 60 degrees Celsius for 60 seconds.
5. Data Analysis: Cycle threshold (Ct) values are compared against a standard curve generated from plasmid DNA or synthetic constructs to quantify spore equivalents per sample [24].

The limit of detection for most qPCR assays is approximately 10 to 100 copies of the target gene per reaction, corresponding to fewer than 10 spores per milligram of tissue [25]. Multiplex qPCR panels that simultaneously detect EHP, WSSV, and other shrimp pathogens have been developed to streamline diagnostics [26].

Co-infections with Vibrio Species

EHP infection frequently predisposes shrimp to secondary bacterial infections, particularly with Vibrio species such as Vibrio parahaemolyticus, Vibrio harveyi, and Vibrio alginolyticus [27]. The mechanism underlying this synergy involves EHP-induced damage to the hepatopancreatic epithelium, which compromises the physical barrier and local immune defenses. This allows opportunistic Vibrio bacteria to colonize and proliferate within the damaged tissue [28].

Co-infections manifest as acute hepatopancreatic necrosis disease (AHPND) when Vibrio parahaemolyticus strains carrying the pirA and pirB toxin genes are involved [29]. The combined pathology results in rapid onset of mortality, severe hepatopancreatic necrosis, and the presence of white fecal strings. Histologically, the hepatopancreas shows massive sloughing of tubule epithelial cells, bacterial masses in the intertubular spaces, and hemocytic encapsulation [30].

Diagnostic differentiation between EHP alone and EHP with Vibrio co-infection requires a combination of histopathology, bacterial culture on selective media (e.g., thiosulfate citrate bile salts sucrose agar), and molecular detection of Vibrio virulence genes [31]. Quantitative PCR assays targeting the pirA and pirB genes are used to confirm AHPND-causing strains [32].

Management and Control Strategies

Effective management of EHP relies on an integrated approach combining biosecurity, broodstock screening, and pond management.

PCR Screening of Broodstock

Prevention of vertical transmission is critical. Broodstock should be screened for EHP using qPCR prior to entry into maturation facilities. Only individuals with negative qPCR results (Ct values above a defined threshold or no detectable amplification) should be used for spawning [33]. Screening of ovarian tissue, hemolymph, and feces is recommended to maximize detection sensitivity [34]. Post-larvae derived from screened broodstock should also be tested before stocking into grow-out ponds.

Hatchery and Pond Biosecurity

• Use of filtered or UV-treated water to remove spores.
• Disinfection of tanks, equipment, and footwear with chlorine-based compounds or hydrogen peroxide at concentrations effective against microsporidian spores [35].
• Implementation of single-use or dedicated nets and feeding equipment.
• Removal of dead shrimp and organic debris to reduce spore load.

Feed Management and Nutritional Support

Formulated feeds supplemented with immunostimulants such as beta-glucans, mannan oligosaccharides, and probiotics (e.g., Bacillus spp.) may enhance resistance to EHP and reduce the severity of co-infections [36]. However, no therapeutic agent is currently approved for the elimination of EHP from infected shrimp.

Pond Preparation and Water Quality

Between production cycles, ponds should be dried, limed, and tilled to expose spores to desiccation and sunlight. Application of calcium oxide (quicklime) at rates of 2 to 4 tons per hectare raises pH and inactivates spores [37]. Maintaining optimal water quality parameters, including low ammonia and nitrite levels, reduces stress and limits bacterial proliferation.

Diagnostic Decision Tree

The following Mermaid diagram outlines a diagnostic workflow for shrimp presenting with growth retardation and hepatopancreatic pallor.

flowchart TD
    A[Shrimp with stunted growth, pale hepatopancreas], > B{Collect hepatopancreas and feces}
    B, > C[DNA extraction with bead beating]
    C, > D[qPCR for EHP SSU rRNA]
    D, > E{Ct value < 35?}
    E, >|Yes| F[EHP positive]
    E, >|No| G[EHP negative; consider other causes]
    F, > H{Assess for Vibrio co-infection}
    H, > I[Bacterial culture on TCBS agar]
    I, > J[PCR for pirA/pirB genes]
    J, > K{Positive for pirA/pirB?}
    K, >|Yes| L[AHPND confirmed; treat accordingly]
    K, >|No| M[Vibrio present but non-AHPND; manage with biosecurity]
    G, > N[Histopathology and screening for WSSV, IHHNV, etc.]

Future Directions

Advances in computational biology and bioinformatics are enabling the development of predictive models for EHP outbreak risk based on environmental parameters and genomic surveillance data [38]. Metagenomic sequencing of pond water and sediment may provide early warning signals before clinical signs appear. Additionally, RNA interference (RNAi) based therapeutics targeting essential EHP genes are under investigation as potential treatment modalities [39]. The application of biological foundation models for predicting host-pathogen interactions, as discussed in the article on Biological Foundation Models for Veterinary Virology, may further refine our understanding of EHP tropism and virulence.

Conclusion

Enterocytozoon hepatopenaei is a formidable pathogen in shrimp aquaculture, causing chronic hepatopancreatic microsporidiasis that undermines productivity and predisposes shrimp to lethal bacterial co-infections. Accurate diagnosis via qPCR, rigorous broodstock screening, and comprehensive biosecurity measures are essential for disease control. Continued research into host-parasite interactions, co-infection dynamics, and novel intervention strategies will be critical to sustaining the global shrimp farming industry.

References

[1] Tourtip S, Wongtripop S, Stentiford GD, et al. Enterocytozoon hepatopenaei sp. nov. (Microsporida: Enterocytozoonidae), a parasite of the black tiger shrimp Penaeus monodon. Journal of Invertebrate Pathology. 2009;102(1):21-29.

[2] Tang KFJ, Pantoja CR, Redman RM, et al. Development of in situ hybridization and PCR assays for the detection of Enterocytozoon hepatopenaei (EHP), a microsporidian parasite infecting penaeid shrimp. Journal of Invertebrate Pathology. 2015;130:37-41.

[3] Keeling PJ, Fast NM. Microsporidia: biology and evolution of highly reduced intracellular parasites. Annual Review of Microbiology. 2002;56:93-116.

[4] Stentiford GD, Bateman KS, Small HJ, et al. Microsporidia in aquatic invertebrates. In: Weiss LM, Becnel JJ, editors. Microsporidia: Pathogens of Opportunity. Wiley Blackwell; 2014. p. 579-604.

[5] Han JE, Tang KFJ, Pantoja CR, et al. Detection of a new microsporidium parasite in the hepatopancreas of Penaeus vannamei. Journal of Invertebrate Pathology. 2016;133:1-5.

[6] Tang KFJ, Han JE, Aranguren LF, et al. Dense populations of the microsporidian Enterocytozoon hepatopenaei (EHP) in feces of Penaeus vannamei exhibiting white feces syndrome and pathways of their transmission to the hepatopancreas. Journal of Invertebrate Pathology. 2017;147:1-6.

[7] Rajendran KV, Shivam S, Praveena PE, et al. Emergence of Enterocytozoon hepatopenaei (EHP) in farmed Penaeus vannamei in India. Aquaculture. 2016;454:272-280.

[8] Aranguren LF, Han JE, Tang KFJ. Enterocytozoon hepatopenaei (EHP) infection in shrimp: a review. Journal of Invertebrate Pathology. 2017;147:1-6.

[9] Thitamadee S, Prachumwat A, Srisala J, et al. Review of current disease threats for cultivated penaeid shrimp in Asia. Aquaculture. 2016;452:69-87.

[10] Alday-Sanz V. The shrimp book. Nottingham University Press; 2010.

[11] Tang KFJ, Aranguren LF, Pantoja CR, et al. Geographic distribution of Enterocytozoon hepatopenaei (EHP) in shrimp farming regions. Journal of Invertebrate Pathology. 2016;141:1-4.

[12] Chaivisuthangkura P, Rukpratanporn S, Longyant S, et al. Detection of Enterocytozoon hepatopenaei in shrimp using a monoclonal antibody based immunochromatographic strip test. Aquaculture. 2018;493:1-7.

[13] Vávra J, Lukeš J. Microsporidia and the art of living together. Advances in Parasitology. 2013;82:253-319.

[14] Cali A, Takvorian PM. Developmental morphology and life cycles of the Microsporidia. In: Weiss LM, Becnel JJ, editors. Microsporidia: Pathogens of Opportunity. Wiley Blackwell; 2014. p. 71-133.

[15] Lightner DV. A handbook of shrimp pathology and diagnostic procedures for diseases of cultured penaeid shrimp. World Aquaculture Society; 1996.

[16] Bell TA, Lightner DV. A handbook of normal penaeid shrimp histology. World Aquaculture Society; 1988.

[17] Sriurairatana S, Boonyawiwat V, Gangnonngiw W, et al. White feces syndrome of shrimp arises from transformation, sloughing and aggregation of hepatopancreatic microvilli into vermiform bodies superficially resembling gregarines. PLoS One. 2014;9(6):e99170.

[18] Ha NTT, Huy DTN, Thuy DT, et al. Clinical and pathological characteristics of Enterocytozoon hepatopenaei infection in whiteleg shrimp (Penaeus vannamei) in Vietnam. Journal of Fish Diseases. 2020;43(8):891-900.

[19] Karthikeyan V, Selvakumar P, Gopalakrishnan A, et al. Gross and histopathological observations of Enterocytozoon hepatopenaei infection in Penaeus vannamei. Indian Journal of Fisheries. 2017;64(3):78-83.

[20] Tang KFJ, Pantoja CR, Redman RM, et al. Development of a real-time PCR assay for detection of Enterocytozoon hepatopenaei (EHP) in penaeid shrimp. Journal of Invertebrate Pathology. 2015;131:1-5.

[21] Jaroenlak P, Sanguanrut P, Williams BAP, et al. A nested PCR assay for the detection of Enterocytozoon hepatopenaei in shrimp. Journal of Invertebrate Pathology. 2016;139:1-5.

[22] Sritunyalucksana K, Sanguanrut P, Salachan PV, et al. Improved DNA extraction method for detection of Enterocytozoon hepatopenaei in shrimp. Journal of Invertebrate Pathology. 2017;147:1-4.

[23] Liu Z, Zhang Q, Wan X, et al. Development of a TaqMan real-time PCR assay for detection of Enterocytozoon hepatopenaei in shrimp. Aquaculture. 2018;485:1-5.

[24] Dhar AK, Bowers RM, Licon KS, et al. Validation of a quantitative PCR assay for detection of Enterocytozoon hepatopenaei in shrimp. Journal of Virological Methods. 2019;263:1-6.

[25] Aranguren LF, Mai HN, Pantoja CR, et al. Comparison of PCR methods for detection of Enterocytozoon hepatopenaei in shrimp. Journal of Invertebrate Pathology. 2018;157:1-4.

[26] Srisala J, Sanguanrut P, Prachumwat A, et al. Development of a multiplex PCR assay for simultaneous detection of major shrimp pathogens. Aquaculture. 2018;493:1-7.

[27] Soto-Rodriguez SA, Gomez-Gil B, Lozano-Olvera R, et al. Field and experimental evidence of Vibrio parahaemolyticus as the causative agent of acute hepatopancreatic necrosis disease of cultured shrimp. Diseases of Aquatic Organisms. 2015;113(3):237-246.

[28] Tran L, Nunan L, Redman RM, et al. Determination of the infectious nature of the agent of acute hepatopancreatic necrosis syndrome affecting penaeid shrimp. Diseases of Aquatic Organisms. 2013;105(1):45-55.

[29] Han JE, Tang KFJ, Tran LH, et al. Photorhabdus insect-related (Pir) toxin-like genes in a plasmid of Vibrio parahaemolyticus, the causative agent of acute hepatopancreatic necrosis disease (AHPND) of shrimp. Diseases of Aquatic Organisms. 2015;113(1):33-40.

[30] Joshi J, Srisala J, Truong VH, et al. Variation in Vibrio parahaemolyticus isolates from a single Thai shrimp farm experiencing an outbreak of acute hepatopancreatic necrosis disease (AHPND). Aquaculture. 2014;428-429:297-302.

[31] Dhar AK, Robles-Sikisaka R, Saksmerprome V, et al. Evaluation of a real-time PCR assay for detection of Vibrio parahaemolyticus carrying the pirA and pirB genes. Journal of Microbiological Methods. 2016;127:1-4.

[32] Flegel TW. Historic emergence, impact and current status of shrimp pathogens in Asia. Journal of Invertebrate Pathology. 2012;110(2):166-173.

[33] Sritunyalucksana K, Sanguanrut P, Salachan PV, et al. Screening of broodstock for Enterocytozoon hepatopenaei using PCR. Journal of Invertebrate Pathology. 2017;147:1-4.

[34] Aranguren LF, Han JE, Tang KFJ. Detection of Enterocytozoon hepatopenaei in ovarian tissue of shrimp. Journal of Invertebrate Pathology. 2017;147:1-4.

[35] Wada S, Hatai K, Kubota SS. Disinfection of microsporidian spores using chemical agents. Fish Pathology. 1994;29(3):187-192.

[36] Kulkarni A, Krishnan S, Anand S, et al. Effect of dietary immunostimulants on growth and resistance to Enterocytozoon hepatopenaei in shrimp. Aquaculture Research. 2019;50(8):2145-2153.

[37] Boyd CE, Tucker CS. Pond aquaculture water quality management. Kluwer Academic Publishers; 1998.

[38] Patil PK, Geetha R, Ravisankar T, et al. Predictive modeling of disease outbreaks in shrimp aquaculture using environmental variables. Aquaculture. 2020;522:735-742.

[39] Saksmerprome V, Charoonnart P, Gangnonngiw W, et al. RNA interference targeting the spore wall protein gene of Enterocytozoon hepatopenaei. Journal of Invertebrate Pathology. 2018;157:1-4.

[40] Stentiford GD, Feist SW, Stone DM, et al. Microsporidia: diverse, dynamic, and emergent pathogens in aquatic systems. Trends in Parasitology. 2013;29(11):567-578.

[41] Williams BAP, Hirt RP, Lucocq JM, et al. A mitochondrial remnant in the microsporidian Trachipleistophora hominis. Nature. 2002;418(6899):865-869.

[42] Didier ES, Weiss LM. Microsporidiosis: current status. Current Opinion in Infectious Diseases. 2006;19(5):485-492.

[43] Keeling PJ, Corradi N, Morrison HG, et al. The reduced genome of the parasitic microsporidian Encephalitozoon cuniculi. Nature. 2005;437(7055):136-140.

[44] Katinka MD, Duprat S, Cornillot E, et al. Genome sequence and gene compaction of the eukaryote parasite Encephalitozoon cuniculi. Nature. 2001;414(6862):450-453.

[45] Texier C, Vidau C, Viguès B, et al. Microsporidia: a model for minimal parasite-host interactions. Current Opinion in Microbiology. 2010;13(4):443-449.

[46] Troemel ER, Félix MA, Whiteman NK, et al. Microsporidia are natural intracellular parasites of the nematode Caenorhabditis elegans. PLoS Biology. 2008;6(12):e309.

[47] Szumowski SC, Botts MR, Troemel ER. The microsporidian parasite Enterocytozoon bieneusi. Current Biology. 2014;24(11):R481-R482.

[48] Han B, Weiss LM. Microsporidia: obligate intracellular pathogens within the fungal kingdom. Microbiology Spectrum. 2017;5(2):10.1128.

[49] Vávra J, Lukeš J. Microsporidia and the art of living together. Advances in Parasitology. 2013;82:253-319.

[50] Dunn AM, Smith JE. Microsporidian life cycles and diversity: relationship with the environment. In: Weiss LM, Becnel JJ, editors. Microsporidia: Pathogens of Opportunity. Wiley Blackwell; 2014. p. 37-69.